We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

66 hedge funds and large institutions have $36.1M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 10

1% less funds holding

Funds holding: 67 → 66 (-1)

4.22% less ownership

Funds ownership: 33.57% → 29.35% (-4.2%)

25% less capital invested

Capital invested by funds: $47.9M → $36.1M (-$11.8M)

32% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 22

Holders
66
Holders Change
-1
Holders Change %
-1.49%
% of All Funds
1.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
22
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$2.33M
2
Citadel Advisors
Citadel Advisors
Florida
+$467K
3
WBG
Wharton Business Group
Pennsylvania
+$449K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$346K
5
SFFS
Stonehage Fleming Financial Services
Jersey
+$314K

Top Sellers

Rank Fund Capital Flow
1
WAP
Wealthcare Advisory Partners
Pennsylvania
-$3.89M
2
Bank of America
Bank of America
North Carolina
-$3.04M
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$924K
4
Morgan Stanley
Morgan Stanley
New York
-$874K
5
MFA
Mayflower Financial Advisors
Massachusetts
-$648K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAS
26
Kestra Advisory Services
Texas
$297K +$122K +5,426 +59%
SFFS
27
Stonehage Fleming Financial Services
Jersey
$285K +$314K +14,000 New
LWM
28
Lodestone Wealth Management
Washington
$256K -$60.2K -2,681 -21%
WAP
29
Wealthcare Advisory Partners
Pennsylvania
$227K -$3.89M -173,244 -94%
NSAM
30
North Star Asset Management
Wisconsin
$226K – – –
CPRC
31
Consolidated Portfolio Review Corp
New York
$220K -$57.7K -2,572 -19%
PFS
32
Prospera Financial Services
Texas
$219K +$241K +10,747 New
CA
33
Cetera Advisors
Colorado
$212K +$516 +23 +0.2%
Wells Fargo
34
Wells Fargo
California
$101K -$130K -5,809 -54%
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$44.1K -$14.6K -650 -25%
BFEC
36
Benjamin F. Edwards & Company
Missouri
$37K – – –
S
37
SignatureFD
Georgia
$30.5K – – –
BFPW
38
BOK Financial Private Wealth
Colorado
$27.1K – – –
SS
39
Sunbelt Securities
Texas
$23.2K – – –
PCFFS
40
Pacific Center for Financial Services
California
$17.1K – – –
IA
41
IFP Advisors
Florida
$16.6K -$88.3K -3,934 -83%
BC
42
Barrett & Company
Rhode Island
$15.3K – – –
Comerica Bank
43
Comerica Bank
Texas
$15K +$16.5K +736 New
RCM
44
Raleigh Capital Management
North Carolina
$13.3K -$3.73K -166 -20%
SPIA
45
Steward Partners Investment Advisory
New York
$13.2K – – –
SSWM
46
Sheets Smith Wealth Management
North Carolina
$11.1K +$12.3K +547 New
Citigroup
47
Citigroup
New York
$8.14K – – –
WIM
48
Westside Investment Management
California
$7.12K – – –
FDCDDQ
49
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.11K – – –
VWM
50
Venturi Wealth Management
Texas
$6.08K -$16.7K -743 -71%
1
2
3 4

IDNA Hedge Fund Activity: Q3 2023 in Review

66 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2023, worth a combined $36.1M — down 25% from $47.9M a quarter earlier.

Fund positioning in IDNA was balanced in Q3 2023: 10 funds opened new positions, 10 closed out, 15 added to existing stakes and 22 trimmed.

The largest buyer was Jane Street, adding an estimated $2.33M. The largest seller was Wealthcare Advisory Partners, cutting an estimated $3.89M.

  • 66 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2023, down from 67 in Q2 2023.
  • Funds reported $36.1M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2023, down 25% quarter-over-quarter.
  • 10 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2023 and 10 closed out, a net change of 0 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2023 was Jane Street, an estimated $2.33M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2023 was Wealthcare Advisory Partners, an estimated $3.89M sold.

Based on aggregated 13F filings for Q3 2023.